SCHEMBL7050481

SCHEMBL7050481

NC(=O)c1ccc2[nH]c(CCc3ccccc3)nc2c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 3/20 0.59
RAB9A P51151 4/20 0.58
NPC1 O15118 2/20 0.58
MAPT P10636 3/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
ALDH1A1 P00352 1/20 0.54
HDAC1 Q13547 2/20 0.48
GAA P10253 1/20 0.48
LMNA P02545 1/20 0.48
HTT P42858 1/20 0.48
CHRM1 P11229 1/20 0.48
CHEK2 O96017 2/20 0.47
KDM4E B2RXH2 1/20 0.47
NTRK1 P04629 2/20 0.46
NTRK2 Q16620 1/20 0.46
HDAC3 O15379 1/20 0.46
HDAC4 P56524 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC10 Q969S8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6374805 0.91 HDAC6 (0.51) HDAC6RAB9ANPC1MAPTSMN1; SMN2
SCHEMBL7050488 0.90 HDAC6 (0.73) HDAC6RAB9ANPC1MAPTSMN1; SMN2
SCHEMBL9598107 0.83 APEX1 (0.45) MAPTCHRM1CHEK2KDM4E
SCHEMBL9569971 0.83 APEX1 (0.45) MAPTALDH1A1CHRM1CHEK2KDM4E
SCHEMBL9028459 0.82 F10 (0.55) CHEK2
SCHEMBL6374801 0.81 HDAC6 (0.62) HDAC6RAB9AMAPTSMN1; SMN2ALDH1A1
SCHEMBL11887806 0.80 APEX1 (0.64) HDAC6RAB9ANPC1ALDH1A1CHRM1
SCHEMBL22533832 0.79 MMP2 (0.50) RAB9ANPC1GAAHTTCHEK2
SCHEMBL3764806 0.79 MAPT (0.78) HDAC6RAB9ANPC1MAPTSMN1; SMN2
SCHEMBL6368287 0.78 PKM (0.44) MAPTGAALMNAHTTCHEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003024451-A1 2-(2-PHENYLETHYL)-BENZIMIDAZOLE-5-CARBOXAMIDE DERIVATIVES AND THEIR USE AS TRYPTASE INHIBITORS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2003-03-27 WO disclosed